SYNLOGIC, INC. Research and Development Expense
SYNLOGIC, INC. (SYBX) reported Research and Development Expense of $49.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-14
- SYNLOGIC, INC. research and development expense for the quarter ending 2026-03-31 was $49.00K, a 122.73% increase year-over-year.
- SYNLOGIC, INC. research and development expense for the quarter ending 2025-03-31 was $22.00K, a 99.71% decline year-over-year.
- SYNLOGIC, INC. research and development expense for the quarter ending 2024-06-30 was $2.20M, a 81.33% decline year-over-year.
- SYNLOGIC, INC. research and development expense for the quarter ending 2024-03-31 was $7.68M, a 38.31% decline year-over-year.
- SYNLOGIC, INC. research and development expense for fiscal 2025 was $43.00K, a 99.53% decline from fiscal 2024.
- SYNLOGIC, INC. research and development expense for fiscal 2024 was $9.15M, a 79.18% decline from fiscal 2023.
- SYNLOGIC, INC. research and development expense for fiscal 2023 was $43.97M, a 15.51% decline from fiscal 2022.
- SYNLOGIC, INC. research and development expense for fiscal 2022 was $52.04M, a 10.43% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | $43.00K 10-K · filed 2026-03-12 | |||||||
| 2025-03-31 | $22.00K 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | $9.15M 10-K · filed 2026-03-12 | |||||||
| 2024-06-30 | $2.20M 10-Q · filed 2024-08-08 | $9.88M 10-Q · filed 2024-08-08 | $20.02M derived: sum of 3 quarters · filed 2025-05-08 | $29.63M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-03-31 | $7.68M 10-Q · filed 2025-05-08 | $17.82M derived: sum of 2 quarters · filed 2025-05-08 | $27.44M derived: sum of 3 quarters · filed 2025-05-08 | $39.20M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $10.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $19.76M derived: sum of 2 quarters · filed 2025-03-06 | $31.52M derived: sum of 3 quarters · filed 2025-03-06 | $43.97M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $9.62M 10-Q · filed 2023-11-09 | $21.38M derived: sum of 2 quarters · filed 2024-08-08 | $33.83M 10-Q · filed 2023-11-09 | $47.47M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-06-30 | $11.77M 10-Q · filed 2024-08-08 | $24.21M 10-Q · filed 2024-08-08 | $37.85M derived: sum of 3 quarters · filed 2024-08-08 | $52.46M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $12.45M 10-Q · filed 2024-05-14 | $26.09M derived: sum of 2 quarters · filed 2024-05-14 | $40.70M derived: sum of 3 quarters · filed 2024-05-14 | $52.76M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $13.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $28.25M derived: sum of 2 quarters · filed 2024-03-19 | $40.31M derived: sum of 3 quarters · filed 2024-03-19 | $52.04M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $14.61M 10-Q · filed 2023-11-09 | $26.67M derived: sum of 2 quarters · filed 2023-11-09 | $38.41M 10-Q · filed 2023-11-09 | $50.28M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $12.06M 10-Q · filed 2023-08-10 | $23.80M 10-Q · filed 2023-08-10 | $35.67M derived: sum of 3 quarters · filed 2023-08-10 | $49.02M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $11.74M 10-Q · filed 2023-05-11 | $23.61M derived: sum of 2 quarters · filed 2023-05-11 | $36.97M derived: sum of 3 quarters · filed 2023-05-11 | $47.69M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $25.23M derived: sum of 2 quarters · filed 2023-03-29 | $35.95M derived: sum of 3 quarters · filed 2023-03-29 | $47.13M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $13.36M 10-Q · filed 2022-11-10 | $24.07M derived: sum of 2 quarters · filed 2022-11-10 | $35.25M 10-Q · filed 2022-11-10 | $46.66M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $10.72M 10-Q · filed 2022-08-11 | $21.90M 10-Q · filed 2022-08-11 | $33.31M derived: sum of 3 quarters · filed 2022-08-11 | $43.79M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $11.18M 10-Q · filed 2022-05-12 | $22.59M derived: sum of 2 quarters · filed 2022-05-12 | $33.07M derived: sum of 3 quarters · filed 2022-05-12 | $45.98M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $11.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $21.89M derived: sum of 2 quarters · filed 2022-03-17 | $34.80M derived: sum of 3 quarters · filed 2022-03-17 | $47.47M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $10.48M 10-Q · filed 2021-11-10 | $23.39M derived: sum of 2 quarters · filed 2021-11-10 | $36.07M 10-Q · filed 2021-11-10 | $47.32M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $12.91M 10-Q · filed 2021-08-12 | $25.59M 10-Q · filed 2021-08-12 | $36.84M derived: sum of 3 quarters · filed 2021-08-12 | $47.40M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $12.68M 10-Q · filed 2021-05-13 | $23.93M derived: sum of 2 quarters · filed 2021-05-13 | $34.49M derived: sum of 3 quarters · filed 2021-05-13 | $44.20M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $11.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $21.82M derived: sum of 2 quarters · filed 2021-03-25 | $31.52M derived: sum of 3 quarters · filed 2021-03-25 | $41.91M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $10.56M 10-Q · filed 2020-11-05 | $20.27M derived: sum of 2 quarters · filed 2020-11-05 | $30.65M 10-Q · filed 2020-11-05 | $39.52M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $9.70M 10-Q · filed 2020-08-06 | $20.09M 10-Q · filed 2020-08-06 | $28.95M derived: sum of 3 quarters · filed 2020-08-06 | $38.89M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $10.38M 10-Q · filed 2020-05-08 | $19.25M derived: sum of 2 quarters · filed 2020-05-08 | $29.18M derived: sum of 3 quarters · filed 2020-05-08 | $40.06M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $8.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $18.80M derived: sum of 2 quarters · filed 2020-03-12 | $29.67M derived: sum of 3 quarters · filed 2020-03-12 | $38.03M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $9.93M 10-Q · filed 2019-11-12 | $20.81M derived: sum of 2 quarters · filed 2019-11-12 | $29.17M 10-Q · filed 2019-11-12 | $36.90M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $10.87M 10-Q · filed 2019-08-08 | $19.23M 10-Q · filed 2019-08-08 | $26.97M derived: sum of 3 quarters · filed 2019-08-08 | $35.92M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $8.36M 10-Q · filed 2019-05-09 | $16.10M derived: sum of 2 quarters · filed 2019-05-09 | $25.05M derived: sum of 3 quarters · filed 2019-05-09 | $33.58M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $7.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $16.69M derived: sum of 2 quarters · filed 2019-03-12 | $25.22M derived: sum of 3 quarters · filed 2019-03-12 | $30.34M 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | $8.96M 10-Q · filed 2018-11-13 | $17.49M derived: sum of 2 quarters · filed 2018-11-13 | $22.61M 10-Q · filed 2018-11-13 | $24.95M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $8.53M 10-Q · filed 2018-08-09 | $5.08M 10-Q · filed 2017-08-04 | $13.65M 10-Q · filed 2018-08-09 | $5.32M 10-Q · filed 2017-08-04 | $15.99M derived: sum of 3 quarters · filed 2018-08-09 | $20.12M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | $5.12M 10-Q · filed 2018-05-15 | $242.00K 10-Q · filed 2017-05-09 | $7.46M derived: sum of 2 quarters · filed 2018-05-15 | $11.59M derived: sum of 3 quarters · filed 2018-05-15 | $15.27M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $2.34M 10-K · filed 2017-03-15 | $6.47M derived: sum of 2 quarters · filed 2017-11-13 | $10.16M derived: sum of 3 quarters · filed 2017-11-13 | $15.01M 10-K · filed 2018-03-20 | $13.93M 10-K · filed 2017-03-15 | |||
| 2016-09-30 | $4.13M 10-Q · filed 2017-11-13 | $3.38M 10-Q · filed 2016-11-10 | $7.82M derived: sum of 2 quarters · filed 2017-11-13 | $9.88M 10-Q · filed 2017-11-13 | $11.59M 10-Q · filed 2016-11-10 | $18.70M derived: sum of 4 quarters · filed 2017-11-13 | ||
| 2016-06-30 | $3.68M 10-Q · filed 2017-08-04 | $8.21M 10-Q · filed 2017-08-04 | $14.57M derived: sum of 3 quarters · filed 2017-08-04 | $19.25M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $4.52M 10-Q · filed 2017-05-09 | $10.89M derived: sum of 2 quarters · filed 2017-05-09 | $15.57M derived: sum of 3 quarters · filed 2017-05-09 | $20.07M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | $6.36M 10-K · filed 2017-03-15 | $11.05M derived: sum of 2 quarters · filed 2017-03-15 | $15.54M derived: sum of 3 quarters · filed 2017-03-15 | $18.95M 10-K · filed 2017-03-15 | ||||
| 2015-09-30 | $4.68M 10-K · filed 2017-03-15 | $9.18M derived: sum of 2 quarters · filed 2017-03-15 | $12.58M 10-Q · filed 2016-11-10 | $16.09M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | $4.50M 10-K · filed 2017-03-15 | $7.90M 10-Q · filed 2016-08-15 | $11.40M derived: sum of 3 quarters · filed 2017-03-15 | $14.19M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | $3.40M 10-K · filed 2017-03-15 | $6.90M derived: sum of 2 quarters · filed 2017-03-15 | $9.69M derived: sum of 3 quarters · filed 2017-03-15 | $11.76M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | $3.50M 10-K · filed 2016-03-30 | $6.29M derived: sum of 2 quarters · filed 2016-03-30 | $8.36M derived: sum of 3 quarters · filed 2016-03-30 | $10.54M 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | $2.79M 10-K · filed 2016-03-30 | $4.86M derived: sum of 2 quarters · filed 2016-03-30 | $7.04M 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | $2.07M 10-K · filed 2016-03-30 | $4.26M derived: sum of 2 quarters · filed 2016-03-30 | ||||||
| 2014-03-31 | $2.19M 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | $4.39M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |